Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision from v3.3.3 to v3.3.4 appears as a UI/version label update on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:38:01.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added a new Locations section and entry for Beijing Municipality; the old Beijing Municipality Locations label was removed and the page now shows Revision: v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T07:56:36.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2 in the page footer.
    Difference
    0.1%
    Check dated 2025-12-01T16:17:31.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.3.1 added and v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:13:22.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Removal of the general government funding and operating-status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:10:11.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots; the page content appears unchanged. The page continues to present study details for NCT04695470.
    Difference
    0.5%
    Check dated 2025-11-03T00:46:32.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.